Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism

Journal of Vascular Surgery

Volumn 47, Issue 3, 2008, Pages 566-570

  Mustafa, Stefan ^a   Weltermann, Ansgar ^a   Fritsche, Robert ^a   Marsik, Claudia ^a   Wagner, Oswald ^a   Kyrle, Paul A ^a   Eichinger, Sabine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; WILD TYPE;

ADULT; AUSTRIA; BLOOD COAGULATION; DINUCLEOTIDE REPEATS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 39249083836     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.09.060     Document Type: Article

References (23)

1. Kyrle P.A., and Eichinger S. Deep vein thrombosis. Lancet 365 (2005) 1163-1174
2. Bach F.H. Heme oxygenase-1 as a protective gene. Wien Klin Wochenschr 114 Suppl 4 (2002) 1-3
3. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2 (1988) 2557-2568
4. Lindenblatt N., Bordel R., Schareck W., Menger M.D., and Vollmar B. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler Thromb Vasc Biol 24 (2004) 601-606
5. Fujita T., Toda K., Karimova A., Yan S.F., Naka Y., Yet S.F., et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7 (2001) 598-604
6. Brune B., and Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32 (1987) 497-504
7. Mansouri A., and Perry C.A. Alteration of platelet aggregation by cigarette smoke and carbon monoxide. Thromb Haemost 48 (1982) 286-288
8. Gende O.A. Carbon monoxide inhibits capacitative calcium entry in human platelets. Thromb Res 114 (2004) 113-119
9. Nowell S.A., Leakey J.E., Warren J.F., Lang N.P., and Frame L.T. Identification of enzymes responsible for the metabolism of heme in human platelets. J Biol Chem 273 (1998) 33342-33346
10. Durante W. Carbon monoxide and bile pigments: surprising mediators of vascular function. Vasc Med 7 (2002) 195-202
11. Soares M.P., Usheva A., Brouard S., Berberat P.O., Gunther L., Tobiasch E., et al. Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal 4 (2002) 321-329
12. Chen Y.H., Lin S.J., Lin M.W., Tsai H.L., Kuo S.S., Chen J.W., et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111 (2002) 1-8
13. Gulesserian T., Wenzel C., Endler G., Sunder-Plassmann R., Marsik C., Mannhalter C., et al. Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant. Clin Chem 51 (2005) 1661-1665
14. Ono K., Goto Y., Takagi S., Baba S., Tago N., Nonogi H., et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 173 (2004) 315-319
15. Schillinger M., Exner M., Minar E., Mlekusch W., Mullner M., Mannhalter C., et al. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 43 (2004) 950-957
16. Yamada N., Yamaya M., Okinaga S., Nakayama K., Sekizawa K., Shibahara S., et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66 (2000) 187-195
17. Kyrle P.A., Minar E., Bialonczyk C., Hirschl M., Weltermann A., and Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350 (2004) 2558-2563
18. Cooper D.N., Nussbaum R.L., and Krawczak M. Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 110 (2002) 207-208
19. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-1
20. Ferroni P., Basili S., Falco A., and Davi G. Oxidant stress and platelet activation in hypercholesterolemia. Antioxid Redox Signal 6 (2004) 747-756
21. Hirai H., Kubo H., Yamaya M., Nakayama K., Numasaki M., Kobayashi S., et al. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 102 (2003) 1619-1621
22. Cambien B., and Wagner D.D. A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med 10 (2004) 179-186
23. Kyrle P.A., Hron G., Eichinger S., and Wagner O. Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 97 (2007) 880-883